Study on Antidepressants in Pregnancy
A recent study examining over half a million pregnancies has concluded that taking antidepressants during pregnancy doesn’t raise the likelihood of children developing autism or attention deficit hyperactivity disorder (ADHD).
Conducted by researchers at the University of Hong Kong and published in Lancet Psychiatry, the analysis compiled data from 37 different studies involving about 600,000 pregnant women who used antidepressants, alongside 25 million women who didn’t during their pregnancies.
Initially, the analysis suggested a 35% increased risk of ADHD and a 69% increased risk of autism associated with antidepressant use. However, after considering important factors like pre-existing mental health conditions, this link was no longer significant. This means the meta-analysis ultimately found no strong correlation between antidepressant use during pregnancy and a heightened risk of autism or ADHD in children, once factors such as the mother’s mental health were accounted for.
Dr. Wing-Chung Chang, the lead researcher, addressed common concerns among expectant parents about the effects of medication. “Our study offers reassuring evidence that widely used antidepressants do not elevate the risk of neurodevelopmental disorders, including autism and ADHD, in children,” he stated.
He further emphasized that while all medication poses some risks, ceasing antidepressant use during pregnancy can also lead to increased chances of relapse for women battling moderate to severe depression. Doctors and patients must carefully weigh the pros and cons of continuing treatment against the potential risks of leaving depression untreated.
Interestingly, while a slight increase in risk was observed for children of women using antidepressants during pregnancy, this risk vanished when considering other factors. The study also noted that children of fathers who used antidepressants or mothers who had used them prior to pregnancy showed similar patterns.
This could indicate that the elevated risk of autism and ADHD isn’t necessarily caused by the antidepressants themselves, but rather influenced by other variables, including genetics.
The research also observed no significant difference in risk between high and low doses of antidepressants. However, limitations were noted; for instance, there was no data on socioeconomic status, lifestyle risk factors, or low birthweight. It’s also important to keep in mind that women prescribed antidepressants often experience more severe depression than those who aren’t, so some biases might still exist even after controlling for various factors.
James Walker, a professor emeritus at the University of Leeds, highlighted the importance of this research in clarifying recent worries surrounding the effects of medications taken by mothers during pregnancy. He advised, “The straightforward message is that women experiencing moderate or severe depression shouldn’t discontinue their antidepressants out of fear of causing autism or ADHD.” He noted that untreated depression can lead to serious risks for both mother and child, including premature birth and difficulties with bonding after birth. For those dealing with milder depression, non-medication approaches are typically recommended first, in line with current guidelines. Ultimately, decisions regarding medication during pregnancy should be tailored to each individual and discussed with a knowledgeable healthcare professional.
